With more than 20 COVID-19 vaccines in clinical trials, the collaboration between Johnson & Johnson and Beth Israel Deaconess in Boston is getting $1 billion in U.S. funding.
Lead researcher Dan Barouch charts the road ahead.
(Produced by Dan Fastenberg)